Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741
Author(s) -
Howard L. McLeod,
Daniel J. Sargent,
Sharon Marsh,
Erin M. Green,
Cristi R. King,
Charles S. Fuchs,
Ramesh K. Ramanathan,
Stephen K. Williamson,
B. Findlay,
Stephen N. Thibodeau,
Axel Grothey,
Roscoe F. Morton,
Richard M. Goldberg
Publication year - 2010
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/dcyd-pm18
Subject(s) - colorectal cancer , medicine , adverse effect , pharmacogenetics , oncology , chemotherapy , gastrointestinal cancer , cancer , genotype , biology , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom